Difference between revisions of "Alpha-2 Agonists"
Jump to navigation
Jump to search
(23 intermediate revisions by 7 users not shown) | |||
Line 1: | Line 1: | ||
− | |||
Alpha-2 agonists have sedative, anxiolytic and analgesic effects. | Alpha-2 agonists have sedative, anxiolytic and analgesic effects. | ||
Line 5: | Line 4: | ||
Alpha-2 agonists act on alpha-2 adrenoreceptors, and mimic the effects of the actual ligand binding. The sedative and anxiolytic effects arise from this process leading to pre-synaptic inhibition of noradrenaline release. | Alpha-2 agonists act on alpha-2 adrenoreceptors, and mimic the effects of the actual ligand binding. The sedative and anxiolytic effects arise from this process leading to pre-synaptic inhibition of noradrenaline release. | ||
− | |||
− | |||
− | |||
− | |||
==Actions== | ==Actions== | ||
− | Alpha-2 agonists have a wide range of actions, due to the presence of alpha-2 receptors throughout the body. The most useful | + | Alpha-2 agonists have a wide range of actions, due to the presence of alpha-2 receptors throughout the body. The actions most useful pharmacologically are '''sedation''', '''anxiolysis''' and '''analgesia'''. The drugs also have a huge '''anaesthetic sparing effect''', reducing MAC by 50-95%. They also give '''muscle relaxtion'''. |
Other systems affected by alpha-2 agonists include: | Other systems affected by alpha-2 agonists include: | ||
− | * | + | * Cardiovascular System |
** Post synaptic alpha-2 effects and non-selective action on alpha-1 receptors cause vasoconstriction, hypertension and reflex bradycardia. | ** Post synaptic alpha-2 effects and non-selective action on alpha-1 receptors cause vasoconstriction, hypertension and reflex bradycardia. | ||
− | ** Pre-synaptic inhibition of noradrenaline release gives a reduced sympathetic outflow. This | + | ** Pre-synaptic inhibition of noradrenaline release gives a reduced sympathetic outflow. This dexreases heart rate and offsets vasoconstriction. |
− | * | + | * Respiratory System |
− | ** The drugs cause mild depression of the respiratory | + | ** The drugs cause mild depression of the respiratory systsem. |
− | ** The response to | + | ** The response to hypercapnoea is reduced. |
− | * | + | * Gastrointestinal Tract |
− | ** Alpha-2 agonists cause extreme | + | ** Alpha-2 agonists cause extreme vomitting in dogs and cats. [[#Xylazine|Xylazine]] is the worst culprit for this. |
** Huge reductions in gut motility occur following drug administration, as well as decreased salivation and secretion. | ** Huge reductions in gut motility occur following drug administration, as well as decreased salivation and secretion. | ||
− | * | + | * Endocrine System |
** Alpha-2 agonists inhibit ADH, leading to diuresis. | ** Alpha-2 agonists inhibit ADH, leading to diuresis. | ||
− | ** Insulin is also inhibited, causing hyperglycaemia which leads to osmotic diuresis. This, along with the | + | ** Insulin is also inhibited, causing hyperglycaemia which leads to osmotic diuresis. This, along with the aboce, causes excessive urination. |
− | ** Growth hormone release is triggered by | + | ** Growth hormone release is triggered by alhpa-2 agonists. |
− | * | + | * Urogenital Tract |
** Uterine contraction occurs with alpha-2 agonist administration. | ** Uterine contraction occurs with alpha-2 agonist administration. | ||
==Side Effects and Contraindications== | ==Side Effects and Contraindications== | ||
− | |||
− | |||
==Drugs in this Group== | ==Drugs in this Group== | ||
===Xylazine=== | ===Xylazine=== | ||
− | |||
− | |||
− | |||
− | |||
===Detomidine=== | ===Detomidine=== | ||
− | |||
− | |||
===Medetomidine=== | ===Medetomidine=== | ||
− | |||
− | |||
===Romifidine=== | ===Romifidine=== | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− |
Revision as of 15:52, 3 March 2009
Alpha-2 agonists have sedative, anxiolytic and analgesic effects.
Mechanism of Action
Alpha-2 agonists act on alpha-2 adrenoreceptors, and mimic the effects of the actual ligand binding. The sedative and anxiolytic effects arise from this process leading to pre-synaptic inhibition of noradrenaline release.
Actions
Alpha-2 agonists have a wide range of actions, due to the presence of alpha-2 receptors throughout the body. The actions most useful pharmacologically are sedation, anxiolysis and analgesia. The drugs also have a huge anaesthetic sparing effect, reducing MAC by 50-95%. They also give muscle relaxtion.
Other systems affected by alpha-2 agonists include:
- Cardiovascular System
- Post synaptic alpha-2 effects and non-selective action on alpha-1 receptors cause vasoconstriction, hypertension and reflex bradycardia.
- Pre-synaptic inhibition of noradrenaline release gives a reduced sympathetic outflow. This dexreases heart rate and offsets vasoconstriction.
- Respiratory System
- The drugs cause mild depression of the respiratory systsem.
- The response to hypercapnoea is reduced.
- Gastrointestinal Tract
- Alpha-2 agonists cause extreme vomitting in dogs and cats. Xylazine is the worst culprit for this.
- Huge reductions in gut motility occur following drug administration, as well as decreased salivation and secretion.
- Endocrine System
- Alpha-2 agonists inhibit ADH, leading to diuresis.
- Insulin is also inhibited, causing hyperglycaemia which leads to osmotic diuresis. This, along with the aboce, causes excessive urination.
- Growth hormone release is triggered by alhpa-2 agonists.
- Urogenital Tract
- Uterine contraction occurs with alpha-2 agonist administration.